Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Mayr

Showing results (281-290 of 292) with videos related to

Pageof 30
Sort By:
Veterinary Immunology and Immunopathology|March 31, 2012
A systemic vaccine based on Escherichia coli O157:H7 bacterial ghosts (BGs) reduces the excretion of E. coli O157:H7 in calvesD A Vilte, M Larzábal, U B Mayr, et al.
Frontiers in Medicine|September 2, 2025
Comprehensive pre- and in-hospital near-infrared-spectroscopy (NIRS) monitoring after return of spontaneous circulation predicts neurological outcome following out-of-hospital cardiac arrest: a prospective observational study and literature reviewSebastian Schnaubelt, Andrea Kornfehl, Felix Eibensteiner, et al.
Critical Care Explorations|October 30, 2025
Genetic Variation in the Alternative Complement Pathway Contributes to Individual Susceptibility to Bacteremia and SepsisKyle Inman, Jonathan Chernus, Myoungkeun Lee, et al.
Critical Care Medicine|February 13, 2019
Immune Checkpoint Inhibition in Sepsis: A Phase 1b Randomized, Placebo-Controlled, Single Ascending Dose Study of Antiprogrammed Cell Death-Ligand 1 Antibody (BMS-936559)Richard S Hotchkiss, Elizabeth Colston, Sachin Yende, et al.
JAMA Network Open|June 11, 2026
Remote Monitoring Approaches to Reduce Readmissions After Infection and Sepsis: A Randomized Clinical TrialSachin Yende, Victor B Talisa, Kristin Mayes, et al.
Journal of Biotechnology|September 16, 1999
Extended recombinant bacterial ghost systemW Lubitz, A Witte, F O Eko, et al.
Intensive Care Medicine|April 27, 2026
Risk heterogeneity within hypoinflammatory acute respiratory failure: continuous probabilities identify high-risk patients masked by binary classificationNanditha Venkatesan, Faraaz Ali Shah, William Bain, et al.
Critical Care Explorations|October 16, 2025
Relationship Between Phenotyping and Individualized Absolute Risk Differences in Sepsis: A Secondary Analysis of Two Approaches in Two Multicenter TrialsVictor B Talisa, Sachin P Yende, Derek C Angus, et al.
Critical Care Medicine|October 23, 2024
Heterogeneity in the Effect of Early Goal-Directed Therapy for Septic Shock: A Secondary Analysis of Two Multicenter International TrialsFaraaz Ali Shah, Victor B Talisa, Chung-Chou H Chang, et al.
Intensive Care Medicine|October 3, 2019
Immune checkpoint inhibition in sepsis: a Phase 1b randomized study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of nivolumabRichard S Hotchkiss, Elizabeth Colston, Sachin Yende, et al.
Pageof 30

Showing results (281-290 of 292) with videos related to

Sort By:
Pageof 30
Veterinary Immunology and Immunopathology|March 31, 2012
A systemic vaccine based on Escherichia coli O157:H7 bacterial ghosts (BGs) reduces the excretion of E. coli O157:H7 in calvesD A Vilte, M Larzábal, U B Mayr, et al.
Frontiers in Medicine|September 2, 2025
Comprehensive pre- and in-hospital near-infrared-spectroscopy (NIRS) monitoring after return of spontaneous circulation predicts neurological outcome following out-of-hospital cardiac arrest: a prospective observational study and literature reviewSebastian Schnaubelt, Andrea Kornfehl, Felix Eibensteiner, et al.
Critical Care Explorations|October 30, 2025
Genetic Variation in the Alternative Complement Pathway Contributes to Individual Susceptibility to Bacteremia and SepsisKyle Inman, Jonathan Chernus, Myoungkeun Lee, et al.
Critical Care Medicine|February 13, 2019
Immune Checkpoint Inhibition in Sepsis: A Phase 1b Randomized, Placebo-Controlled, Single Ascending Dose Study of Antiprogrammed Cell Death-Ligand 1 Antibody (BMS-936559)Richard S Hotchkiss, Elizabeth Colston, Sachin Yende, et al.
JAMA Network Open|June 11, 2026
Remote Monitoring Approaches to Reduce Readmissions After Infection and Sepsis: A Randomized Clinical TrialSachin Yende, Victor B Talisa, Kristin Mayes, et al.
Journal of Biotechnology|September 16, 1999
Extended recombinant bacterial ghost systemW Lubitz, A Witte, F O Eko, et al.
Intensive Care Medicine|April 27, 2026
Risk heterogeneity within hypoinflammatory acute respiratory failure: continuous probabilities identify high-risk patients masked by binary classificationNanditha Venkatesan, Faraaz Ali Shah, William Bain, et al.
Critical Care Explorations|October 16, 2025
Relationship Between Phenotyping and Individualized Absolute Risk Differences in Sepsis: A Secondary Analysis of Two Approaches in Two Multicenter TrialsVictor B Talisa, Sachin P Yende, Derek C Angus, et al.
Critical Care Medicine|October 23, 2024
Heterogeneity in the Effect of Early Goal-Directed Therapy for Septic Shock: A Secondary Analysis of Two Multicenter International TrialsFaraaz Ali Shah, Victor B Talisa, Chung-Chou H Chang, et al.
Intensive Care Medicine|October 3, 2019
Immune checkpoint inhibition in sepsis: a Phase 1b randomized study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of nivolumabRichard S Hotchkiss, Elizabeth Colston, Sachin Yende, et al.
Pageof 30